Skip to main content
. 2015 Mar 11;32(11):3526–3540. doi: 10.1007/s11095-015-1657-7
Phase Originator Common name Specificity target name Targeted disease
1 Immunomedics IMMU-110/MEDI-115 anti-CD74 NHL/CLL